MedTrace Logo

Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia

NCT00199095 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-03-20

No results posted yet for this study

Summary

The aim of this study is to test feasibility and efficacy of a dose reduced chemotherapy in elderly patients with newly diagnosed acute lymphoblastic leukemia. The regimen consists of induction phase I and II followed by cyclic consolidation cycles, reinduction and maintenance therapy

Conditions

  • Adult Acute Lymphocytic Leukemia

Interventions

DRUG

Adriamycin

DRUG

Cyclophosphamide

DRUG

Cytarabine

DRUG

Dexamethasone

DRUG

Idarubicin

DRUG

Ifosfamide

DRUG

Methotrexate

DRUG

Mercaptopurine

DRUG

VM26

DRUG

Vincristine

Sponsors & Collaborators

  • Goethe University

    lead OTHER

Principal Investigators

  • Dieter Hoelzer, MD · University Hospital Frankfurt, Medical Dept. II

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-02-28
Primary Completion
2003-06-30
Completion
2003-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00199095 on ClinicalTrials.gov